Early Colorectal Cancer: Patient-Targeted and Organ-Preserving Treatment
ECOPOP is an international research consortium redefining treatment of early colorectal cancer through organ-preserving, evidence-based care.
Colorectal cancer is the second leading cause of cancer-related death in Europe. While screening programs enable early detection, current standard treatment remains surgical removal — often invasive and burdensome for patients. ECOPOP aims to shift this paradigm towards less invasive, organ-preserving approaches while maintaining oncological safety.
Reducing complications and improving quality of life through minimally invasive treatments.
Large international randomized trials comparing surgery with endoscopic approaches.
Integrating carbon footprint and cost-effectiveness into clinical decision-making.
ECOPOP brings together leading institutions across Europe and the United States, combining expertise in gastroenterology, surgery, oncology, AI, and biomarker research to redefine treatment pathways for early colorectal cancer.
Multicentre randomized trials across Europe are being initiated.
New centres and collaborators are joining the ECOPOP network.
Work on future clinical recommendations has started.
ECOPOP is a Horizon Europe-funded research consortium focused on improving early colorectal cancer treatment through organ-preserving approaches.
Scope: multicentre clinical trials, AI, biomarkers
Geography: Europe & US
Centres: 15+
For collaboration, trial participation or general inquiries, contact the ECOPOP coordination team.
Email:
ecopop@gumed.edu.pl
Location:
Medical University of Gdańsk